1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl-)-1-pentanone has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kubohara, Y | 1 |
1 other study(ies) available for 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl-)-1-pentanone and Leukemia
| Article | Year |
|---|---|
Effects of differentiation-inducing factors of Dictyostelium discoideum on human leukemia K562 cells: DIF-3 is the most potent anti-leukemic agent.
Topics: Animals; Antineoplastic Agents; Calcium; Cell Count; Cell Differentiation; Cell Division; Dictyostelium; DNA; Dose-Response Relationship, Drug; Hexanones; Humans; K562 Cells; Leukemia; Pentanones; Phenols; Resorcinols | 1999 |